What Oriola Oy does

Oriola Oy (legal entity Oriola Corporation) is a publicly listed Nordic healthcare company headquartered in Espoo, Finland, operating 70 distribution locations across Finland, Sweden, and Denmark. The company is organized around three service pillars: Distribution Services (GDP-compliant pharmaceutical and health product logistics, warehousing, cold chain technology, and vaccine distribution), Wholesale Services (connecting health and wellbeing suppliers with Nordic resellers), and Advisory Services (pharmaceutical lifecycle support including market entry, regulatory affairs, clinical trials, market access, market intelligence, medical information, translations, and research services). In 2024 Oriola delivered 162 million pharmaceutical products and reduced Scope 1 and 2 emissions by 40% versus the 2023 baseline.

Underlying technology consists of a GDP-compliant supply chain with cold chain and vaccine distribution capabilities, quality control processes integrated through warehousing and delivery operations, and reporting/analytics services for pharmaceutical customers. The company does not disclose proprietary AI/ML systems, and its technology stack appears concentrated in logistics execution and regulatory compliance rather than data-driven differentiation.

Oriola's business model is B2B and relationship-driven, with revenue generated from transaction fees on distribution and wholesale flows plus professional services fees for advisory work. Customers are segmented into pharmaceutical companies, pharmacies (including dose dispensing, research pharmacy network, and special licensed medicines), veterinarians, health and wellbeing suppliers, retailers, and e-commerce platforms. Pricing is quote-based and negotiated directly, with no public price list. The company is publicly listed in Finland, maintains an investor relations infrastructure stretching back more than a decade, and is currently building a new distribution centre in Järvenpää with construction scheduled to start in June 2026.

Name

Oriola Oy

Legal name

Oriola Corporation

Website

https://oriola.fi

Company type

Public

Operating status

Operating

Headcount range

51–100 employees

Short description

Oriola Corporation is a publicly listed Nordic pharmaceutical distribution, wholesale, and advisory company operating 70 locations across Finland, Sweden, and Denmark, serving pharmaceutical companies, pharmacies, veterinarians, and health-product retailers with GDP-compliant logistics and lifecycle advisory services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

akta.pro secondary industry

Pharmacy & Health Essentials Delivery (CRAFAFAI)

Keywords

• Pharmaceutical distribution services
• Cold chain logistics
• Wholesale health products
• Pharmacy supply services
• Pharmaceutical advisory consulting

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Distribution Services: Distribution services for pharmaceuticals and health products including quality control, warehousing, logistics, cold chain technology and vaccine distribution. Revenue is generated through service fees for managing the supply chain for pharmaceutical companies, pharmacies, healthcare providers, veterinarians, retailers, and e-commerce.
2. Wholesale Services: Wholesale services connecting health and wellbeing suppliers and resellers. Revenue is generated through wholesale margins on product sales, providing suppliers with market reach expansion and resellers with reliable product access and local expertise.
3. Advisory Services: Tailored advisory services across the entire product lifecycle including market entry, regulatory compliance, commercial strategy, market insights, clinical trial services, market access and tenders, medical and regulatory affairs, medical information and safety, medical translations, and research services. Revenue generated through professional services fees.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Oriola provides GDP-compliant pharmaceutical distribution and logistics, wholesale of health and wellbeing products, and tailored advisory services across the Nordic region. The company serves pharmaceutical companies, pharmacies, veterinarians, retailers, and e-commerce platforms, combining cold chain technology, vaccine distribution expertise, quality-controlled warehousing, and regulatory and market access advisory services into a unified Nordic healthcare supply partner offering.

Product overview

Oriola is a Nordic pharmaceutical distribution, wholesale, and advisory services company operating in Finland, Sweden, and Denmark. The company operates as a unified service platform organized into three core service pillars: Distribution Services (GDP-compliant pharmaceutical and health product logistics including cold chain technology and vaccine distribution), Wholesale Services (connecting health and wellbeing suppliers with Nordic resellers), and Advisory Services (comprehensive pharmaceutical lifecycle support including clinical trials, market access, regulatory affairs, and market intelligence). These core services are supported by specialized sub-services including dose dispensing, research pharmacy network, special licensed medicines, and various advisory modules. The company delivers 162 million pharmaceutical products annually across 7 locations in the Nordic region.

Differentiator

Problem solved

Functional benefit

Products and services

• Distribution Services GDP-compliant pharmaceutical and health product distribution and logistics for pharmaceutical companies, pharmacies, veterinarians, and healthcare providers across Finland, Sweden, and Denmark, including quality control, warehousing, cold chain handling, and vaccine distribution capability.
• Wholesale Services Nordic wholesale of health and wellbeing products that connects suppliers and resellers, providing reliable product access, local market expertise, and streamlined distribution operations across Finland, Sweden, and Denmark.
• Advisory Services Tailored pharmaceutical advisory services for the entire product lifecycle, including market entry strategy, regulatory compliance, commercial strategy, and market insights for the Nordic healthcare market.
• Vaccine Distribution Specialized vaccine distribution service combining cold chain logistics expertise with GDP-compliant handling for pharmaceutical companies.
• Warehousing and Distribution Comprehensive GDP-compliant warehousing and distribution services for pharmaceutical companies operating in Nordic markets.
• Reporting and Analytics Supply chain reporting and analytics services that enable pharmaceutical companies to track distribution performance and optimize their Nordic supply chain operations.
• Dose Dispensing Specialized dose dispensing service for pharmacies to support patient medication management and improve adherence.
• Research Pharmacy Network Network of pharmacies structured to support clinical research and pharmaceutical trials, providing a Nordic channel for evidence generation and clinical trial operations.
• Special Licensed Medicines for Pharmacies Distribution service providing pharmacies with reliable access to special licensed medicines that require regulatory oversight and controlled handling.
• Special Licensed Medicines for Veterinarians Specialized pharmaceutical distribution service for veterinarians providing access to special licensed medicines and veterinary pharmaceuticals.
• Clinical Trial Services Advisory support for clinical trial planning and operations in the Nordic region, integrating Oriola's research pharmacy network and regulatory knowledge.
• Market Access and Tenders Advisory services supporting pharmaceutical companies in securing market access and successfully participating in tender processes in Nordic healthcare systems.
• Market Entry and Commercial Services Market entry strategy and commercial services for pharmaceutical companies entering or expanding within Nordic markets.
• Market Intelligence Market intelligence services providing pharmaceutical companies with insights into Nordic healthcare markets, commercial opportunities, and competitive dynamics.
• Medical and Regulatory Affairs Regulatory and medical affairs support combining deep knowledge of Nordic healthcare systems and regulatory requirements to help pharmaceutical companies remain compliant.
• Medical Information and Safety Medical information and pharmacovigilance safety services delivered across Europe for pharmaceutical companies managing marketed products.
• Medical Translations Professional medical translation services to support regulatory submissions, product information, and clinical documentation in Nordic and European languages.
• Research Services Research services supporting pharmaceutical product development, evidence generation, and clinical research planning in Nordic markets.
• Interim Solutions Interim staffing and consulting solutions that allow pharmaceutical companies to flex specialized resources for Nordic operations during transitions or projects.
• Health and Wellbeing Products Wholesale Wholesale distribution of health and wellbeing products across Finland, Sweden, and Denmark for suppliers and resellers.

Quantifiable outcome

• 162 million pharmaceutical products delivered in 2024
• +1 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Alliance Healthcare: Alliance Healthcare (Walgreens Boots Alliance) operates pharmaceutical wholesale and distribution across Europe, comparable in business model to Oriola's wholesale and distribution services, though with broader geographic reach.
• Cencora: Cencora (formerly AmerisourceBergen) is a global pharmaceutical distributor with deep manufacturer and provider relationships. It is a broader incumbent whose services (specialty distribution, consulting) overlap with Oriola's pharma distribution and advisory offerings.
• Phoenix Group: Phoenix Group is the parent of Tamro and a leading European pharmaceutical distributor with operations across the Nordics, overlapping with Oriola in pharma wholesale and customer base, but at much broader continental scale.
• Cardinal Health: Cardinal Health is a major U.S.-headquartered pharmaceutical distributor and healthcare services provider with global operations, comparable to Oriola's distribution and advisory services at a far larger scale.
• McKesson: McKesson is a global pharmaceutical distribution and healthcare services leader with capabilities in pharma logistics, advisory, and biopharma services — a much larger incumbent whose European and global reach contrasts with Oriola's Nordic-only footprint.

Direct peers

• Tamro: Tamro is a Nordic pharmaceutical wholesaler (part of Phoenix Group) operating across Finland, Sweden, and the Baltics, directly competing with Oriola in pharma distribution and wholesale services to pharmacies and manufacturers.
• Norsk Medisinaldepot (NMD): NMD is Norway's principal pharmaceutical wholesaler, directly comparable as a Nordic pharma distributor serving pharmacies and healthcare providers with a similar regulatory-compliant supply chain model.

Others

• Apotea: Apotea is the largest online pharmacy in the Nordics and a relevant counterparty to Oriola's e-commerce distribution channel, sharing the Nordic pharma value chain but operating downstream as a digital retailer.
• Apotek Hjärtat: Apotek Hjärtat is a major Swedish pharmacy retailer and a customer-side counterparty in Oriola's ecosystem; comparable because it sits in the same Nordic pharma value chain and consumes Oriola's distribution and wholesale services.

Emerging players

• Mediq: Mediq is a European healthcare distributor and provider of medical devices and pharmaceuticals to hospitals and pharmacies, partially overlapping with Oriola's distribution and dose dispensing services in adjacent European markets.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/oriola-oy

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oriola Oy